The recall comes down to one lot
Breckenridge Pharmaceutical announced a voluntary nationwide consumer-level recall on November 16, 2026. It covers one lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg in 100-count bottles. The National Drug Code is 51991-817-01, the lot number is PK25110035, and the expiration date is May 2029. The company says the bottles were distributed to wholesalers and pharmacies between October 26 and November 4, 2026. Other strengths and lots are outside the notice as issued.
Breckenridge says the affected lot shared intermediate material with a separate lot in which metal contamination was identified. That other lot did not reach the market. The company says use of capsules from the recalled lot could potentially cut soft tissue in the mouth, esophagus, stomach, or intestine. It was unaware of adverse events assessed as related to the recall when the notice was published.
Use the pharmacy record when the vial has no lot
Begin with the prescription label. Check that the medicine is extended-release propranolol and the strength is 60 mg. The Breckenridge product label describes the 60 mg capsule as white and opaque, with “60” printed on the cap and “RD203” on the body. Those markings identify the product and strength; they do not reveal the recalled lot.
Many pharmacies transfer capsules from a manufacturer’s 100-count bottle into a labeled prescription vial. The NDC may appear on the pharmacy label, while the manufacturer’s lot number may be absent. Keep the vial and call the dispensing pharmacy. Give the prescription number, fill date, strength, NDC if shown, and the recalled lot number PK25110035. Ask the pharmacist to check the source bottle or dispensing record. A capsule’s color and imprint cannot settle the lot question on their own.
Make the same-day call count
Breckenridge directs consumers with product from the recalled lot to stop taking it immediately, contact a physician or other health care provider for medical advice and replacement instructions, and return unused capsules to the pharmacy where they were obtained. The recall service provider, Qualanex, answers questions at 855-736-0807 from 9 a.m. to 5 p.m. Eastern, Monday through Friday.
Prompt professional contact matters because the official propranolol label warns patients against interrupting or discontinuing therapy without physician advice. Abrupt withdrawal of beta-blockers can worsen angina and has been associated with heart attack, including in people whose coronary artery disease may be unrecognized. The recall instruction and the stopping warning belong in the same conversation. Ask the pharmacist or prescriber how to follow the recall safely and how a replacement will be arranged. Do not substitute another capsule, alter the dose, or use somebody else’s prescription.
Write down five details before you call
A short note can make the pharmacy conversation faster: the name and strength, the prescription number, the dispensing pharmacy, the fill date, and every identifier visible on the vial. Add any dose already taken and any symptoms that concern you. Photograph the label for your own record, keeping personal information private. Leave the medicine in its labeled container so the pharmacy can identify it.
If the pharmacist confirms that your prescription came from a different lot, ask whether any further action is needed. If the lot cannot be confirmed immediately, ask what the pharmacy wants you to do while it checks. Record the name of the person you spoke with and the agreed next step. A shared household should review each person’s prescription separately; matching medicine names do not prove that the fills came from the same manufacturer bottle or lot.
Know where problems are reported
Breckenridge advises contacting a physician or health care provider if you experienced a problem that may be related to the product. The company notice also directs consumers to the FDA MedWatch program for adverse reactions or quality problems. The online report asks for details about the person affected, the product, the event, and the reporter. A pharmacist or clinician can help identify the information on the container.
Keep the vial, remaining capsules, receipt, and any replacement instructions until the pharmacy tells you how to return them. For an urgent or severe symptom, seek immediate medical care rather than waiting for a recall line to open. A report can support federal safety monitoring after care is underway. The recall notice was issued with FDA knowledge, and records may be updated; use the linked manufacturer notice for the current identifiers.
Use the label as the final checklist
Read the line once more before ending the call: 60 mg extended-release capsules, 100-count manufacturer bottle, NDC 51991-817-01, lot PK25110035, expiration May 2029. The capsule imprint is “60” over “RD203.” The lot remains the decisive identifier. Ask the pharmacy to spell it back and explain the replacement plan in plain language.
A medicine recall can compress a complex decision into a few anxious minutes. Put the exact codes in front of the person who can check the dispensing record. Keep the manufacturer’s stop-and-contact instruction and the official label’s withdrawal warning together. The practical goal is a confirmed lot, timely professional guidance, and a documented replacement plan.
Published by Spee24. Our editorial approach.
Explore Wellness


